FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered exceptional ...
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart ...
Top 75 percent of investments of First Trust NYSE Arca Biotechnology Index Fund in the biotechnology sector included 22 stocks. This list included Agios Pharmaceuticals, Inc. (AGIO), Biogen Inc. (BIIB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results